Table 4.
Proportion of antimicrobial resistance among non-fermentative Gram-negative bacilli that were most frequently isolated
| Antimicrobial drug | Pseudomonas spp.[17] | Acinetobacter spp.[17] | |||||
|---|---|---|---|---|---|---|---|
| S | I | R | Total | S | R | Total | |
| Piperacillin | 13 (86.7) | 0 (0) | 2 (13.3) | 15 (100) | - | - | - |
| Piperacillin Tazobactam | 13 (86.7) | 0 (0) | 2 (13.3) | 15 (100) | - | - | - |
| Cefepime | 13 (86.7) | 0 (0) | 2 (13.3) | 15 (100) | - | - | - |
| Ceftazidime | 16 (94.1) | 0 (0) | 1 (5.9) | 17 (100) | - | - | - |
| Imipenem | 15 (88.2) | 1 (5.9) | 1 (5.9) | 17 (100) | 3 (17.6) | 14 (82.4) | 17 (100) |
| Meropenem | 14 (82.4) | 3 (17.6) | 0 (0) | 17 (100) | 3 (17.6) | 14 (82.4) | 17 (100) |
| Aztreonam | 1 (6.7) | 12 (80) | 2 (13.3) | 15 (100) | - | - | - |
| Ciprofloxacin | 14 (82.4) | 0 (0) | 3 (17.6) | 17 (100) | 2 (12.5) | 14 (87.5) | 16 (100) |
| Amikacin | 14 (93.3) | 0 (0) | 1 (6.7) | 15 (100) | 3 (17.6) | 14 (82.4) | 17 (100) |
| Gentamicin | 14 (87.5) | 0 (0) | 2 (12.5) | 16 (100) | 3 (17.6) | 14 (82.4) | 17 (100) |
| Sulfamethoxazole Trimethoprim | - | - | - | - | 3 (17.6) | 14 (82.4) | 17 (100) |
Pseudomonas spp.: Pseudomonas aeruginosa: 14, Pseudomonas putida: 3, Acinetobacter spp.: Acinetobacter baumannii:15, Acinetobacter putti:1, Acinetobacter junii:1